Register
Medicines reference
Product

Cyclavance

Ciclosporin · Virbac

1 form: solution. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Choose species and weight; the matching row will be highlighted.
Form Species Dose Frequency Georgia
100 mg/ml, Solution · Cat Cat 0.07 ml/kg
0.07 ml/kg (7 mg/kg) with a little food or into the mouth; daily until controlled, then less often.
· once daily, then every other day, then every 3-4 days
once daily, then every other day, then every 3-4 days Georgia Yes, veterinary
100 mg/ml, Solution · Dog Dog 0.05 ml/kg
0.05 ml/kg (5 mg/kg) straight into the mouth, at least 2 hours before or after food; daily until controlled, then less often.
· once daily, then every other day, then every 3-4 days
once daily, then every other day, then every 3-4 days Georgia Yes, veterinary
Details: pack, label wording, sources, registration

Cyclavance 100 mg/ml, Solution

ciclosporin 100 mg/ml, oral solution for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Long-term control of chronic canine atopic dermatitis after diagnosis and control of flare factors
7.8/10
Good
vetman assessment

Cyclavance

100 mg/ml, ciclosporin 100 mg/ml, oral solution for dogs and cats
Assessed clinical scopeDog · Long-term control of chronic canine atopic dermatitis after diagnosis and control of flare factors · By mouth
Care settingVeterinary-directed long-term outpatient immunomodulatory treatment
vetman score 7.8/10 Good
Evidence confidence: High Georgia: Yes, veterinary · Verified on 18 Oct 2026

A well-supported long-term standard for correctly diagnosed canine atopic dermatitis, with meaningful immunosuppressive precautions.

Regulatory and scientific credibility8.5/10

The exact 100 mg/ml dog-and-cat solution has a current transparent UK SPC and active Georgian veterinary registration.

Clinical efficacy8.5/10

Oral ciclosporin is a consensus-supported effective standard for chronic canine atopic dermatitis, with response-based interval reduction after control.

Safety and tolerability6.5/10

Immunosuppression, malignancy, live-vaccine, diabetes, severe renal disease and reproductive restrictions require careful selection; gastrointestinal effects and infection monitoring are relevant.

Clinical practicality7.5/10

Accurate oral liquid dosing is feasible and frequency can fall after control, but initial daily treatment, food timing in dogs and long-term monitoring create a real burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with malignant disease, within two weeks of live vaccination, or in dogs younger than six months or under 2 kg.
  • Screen and monitor for infection, diabetes and severe renal disease; avoid pregnancy and lactation and review P-glycoprotein substrate combinations.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Long-term control of chronic feline allergic dermatitis after diagnosis and infection screening
7.5/10
Good
vetman assessment

Cyclavance

100 mg/ml, ciclosporin 100 mg/ml, oral solution for dogs and cats
Assessed clinical scopeCat · Long-term control of chronic feline allergic dermatitis after diagnosis and infection screening · By mouth
Care settingVeterinary-directed long-term outpatient immunomodulatory treatment
vetman score 7.5/10 Good
Evidence confidence: Medium Georgia: Yes, veterinary · Verified on 18 Oct 2026

An effective labelled feline option when infection and immunosuppression risks are actively screened and monitored.

Regulatory and scientific credibility8.5/10

The exact 100 mg/ml dog-and-cat solution has a current transparent UK SPC and active Georgian veterinary registration.

Clinical efficacy8.0/10

Oral ciclosporin is an established labelled option for chronic feline allergic dermatitis, but the independent evidence base is smaller than in dogs.

Safety and tolerability6.0/10

FeLV/FIV, malignancy, live vaccines, diabetes, severe renal disease and reproduction are material restrictions; toxoplasmosis risk and infection monitoring are specifically important in cats.

Clinical practicality7.5/10

Accurate oral liquid dosing is feasible and frequency can fall after control, but initial daily treatment, food timing in dogs and long-term monitoring create a real burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use in FeLV- or FIV-positive cats, malignant disease or within two weeks of live vaccination.
  • Screen and monitor for infection, diabetes and severe renal disease; avoid pregnancy and lactation and review P-glycoprotein substrate combinations.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Ciclosporin100 mg/ml
Formulation Type
Solution
Administration route
By mouth
Manufacturer
Virbac · France
Registration
Georgia Yes, veterinary
EU Yes, veterinary
Verified on: 18 Oct 2026
UK Yes, veterinary
№ Vm 05653/3015
Verified on: 18 Oct 2026
US Yes, veterinary
№ ANADA 200-692
Verified on: 18 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 18 Oct 2026
DoseSpeciesWeightRouteFrequencySource
0.07 ml/kg
0.07 ml/kg (7 mg/kg) with a little food or into the mouth; daily until controlled, then less often.
Cat Any weight By mouth once daily, then every other day, then every 3-4 days
VMD SPC 2024
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Cyclavance 100 mg/ml oral solution for dogs and cats - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2024
0.05 ml/kg
0.05 ml/kg (5 mg/kg) straight into the mouth, at least 2 hours before or after food; daily until controlled, then less often.
Dog Any weight By mouth once daily, then every other day, then every 3-4 days
VMD SPC 2024
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Cyclavance 100 mg/ml oral solution for dogs and cats - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2024

Known Contraindications

  • Critical
    Do not use if hypersensitive to ciclosporin or excipients.
    Sources: UK SPC
  • Critical
    Do not use with a history of, or progressive, malignant disease.
    Sources: UK SPC
  • Critical (Dog)
    Do not use in dogs under 6 months of age or under 2 kg.
    Sources: UK SPC
  • Critical (Cat)
    Do not use in cats infected with FeLV.
    Sources: UK SPC
  • Critical (Cat)
    Do not use in cats infected with FIV.
    Sources: UK SPC
  • Warning
    No live vaccines during treatment or within two weeks before or after it.
    Sources: UK SPC
  • Warning
    Not recommended in diabetic animals: it can raise blood glucose.
    Sources: UK SPC
  • Warning
    Not recommended during pregnancy.
    Sources: UK SPC
  • Warning
    Not recommended during lactation (passes into milk).
    Sources: UK SPC
  • Caution
    P-glycoprotein inhibitor: with macrocyclic lactones such as ivermectin or milbemycin, CNS toxicity is possible.
    Sources: UK SPC
  • Caution (Dog)
    Severe renal insufficiency: monitor creatinine closely; avoid other nephrotoxic drugs.
    Sources: UK SPC

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.